glp-1 obesity drug news october 9 2025 Novo, Lilly weight-loss drugs should be first option treatments, European doctors say GLP-1 Overdoses Are Rising as
Description
The category has also gained global attention for its weight-loss benefits
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Nasri F, et al
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
Food and Drug Administration to treat obese adults in June 2021 but has yet to get a nod in Korea
Weber MA, Mansfield TA, Alessi F, Iqbal N, Parikh S, Ptaszynska A
Crespel, A., De Boisvilliers, F., Gros, L., Kervran, A
